John J Mason
Examiner (ID: 6497)
Most Active Art Unit | 2198 |
Art Unit(s) | 2198 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5759615
[patent_doc_number] => 20060210560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'TNF receptor action modulaton'
[patent_app_type] => utility
[patent_app_number] => 11/404081
[patent_app_country] => US
[patent_app_date] => 2006-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7093
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210560.pdf
[firstpage_image] =>[orig_patent_app_number] => 11404081
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/404081 | TNF receptor action modulation | Apr 13, 2006 | Issued |
11/324056 | Method and composition for the delivery of a botulinum neurotoxin for the prevention and treatment of epileptic seizures | Dec 29, 2005 | Abandoned |
Array
(
[id] => 5842187
[patent_doc_number] => 20060121018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Methods and compositions for targeting proteins across the blood brain barrier'
[patent_app_type] => utility
[patent_app_number] => 11/234876
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8692
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121018.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234876 | Methods and compositions for targeting proteins across the blood brain barrier | Sep 22, 2005 | Abandoned |
Array
(
[id] => 856943
[patent_doc_number] => 07375203
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-05-20
[patent_title] => 'Canine cold- and menthol-sensitive receptor 1'
[patent_app_type] => utility
[patent_app_number] => 11/099855
[patent_app_country] => US
[patent_app_date] => 2005-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22359
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/375/07375203.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099855
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099855 | Canine cold- and menthol-sensitive receptor 1 | Apr 5, 2005 | Issued |
Array
(
[id] => 5738429
[patent_doc_number] => 20060008819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, FBH58295FL, 57255, and 57255alt molecules and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/043889
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 174669
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11043889
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/043889 | Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, FBH58295FL, 57255, and 57255alt molecules and uses therefor | Jan 24, 2005 | Abandoned |
Array
(
[id] => 7074803
[patent_doc_number] => 20050148071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Production of tyrosine hydroxylase positive neurons'
[patent_app_type] => utility
[patent_app_number] => 10/985849
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6371
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10985849
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/985849 | Production of tyrosine hydroxylase positive neurons | Nov 9, 2004 | Abandoned |
Array
(
[id] => 7143640
[patent_doc_number] => 20050118565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Systems and methods for assessing neuronal degeneration'
[patent_app_type] => utility
[patent_app_number] => 10/966405
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5806
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118565.pdf
[firstpage_image] =>[orig_patent_app_number] => 10966405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/966405 | Systems and methods for assessing neuronal degeneration | Oct 14, 2004 | Abandoned |
Array
(
[id] => 7211829
[patent_doc_number] => 20050054049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Novel human transporter proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/924751
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9243
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924751
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924751 | Novel human transporter proteins and polynucleotides encoding the same | Aug 23, 2004 | Abandoned |
Array
(
[id] => 5880464
[patent_doc_number] => 20060029546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Materials and methods for identifying anti-schizophrenic agents'
[patent_app_type] => utility
[patent_app_number] => 10/912971
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 28610
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029546.pdf
[firstpage_image] =>[orig_patent_app_number] => 10912971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/912971 | Materials and methods for identifying anti-schizophrenic agents | Aug 5, 2004 | Abandoned |
Array
(
[id] => 7061703
[patent_doc_number] => 20050004065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Hypoxia regulated genes'
[patent_app_type] => utility
[patent_app_number] => 10/857942
[patent_app_country] => US
[patent_app_date] => 2004-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 29630
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20050004065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857942
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857942 | Hypoxia regulated genes | Jun 1, 2004 | Abandoned |
Array
(
[id] => 7263218
[patent_doc_number] => 20040241639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Human tachykinin-related splice variants and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/476591
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14026
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10476591
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/476591 | Human tachykinin-related splice variants and compositions thereof | May 10, 2004 | Abandoned |
Array
(
[id] => 6966021
[patent_doc_number] => 20050232918
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Differentially expressed genes associated with obesity and type 2 diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/826448
[patent_app_country] => US
[patent_app_date] => 2004-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 19214
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232918.pdf
[firstpage_image] =>[orig_patent_app_number] => 10826448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/826448 | Differentially expressed genes associated with obesity and type 2 diabetes | Apr 15, 2004 | Abandoned |
Array
(
[id] => 7020023
[patent_doc_number] => 20050222042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Method for modification of NMDA receptors through inhibition of Src'
[patent_app_type] => utility
[patent_app_number] => 10/814109
[patent_app_country] => US
[patent_app_date] => 2004-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12563
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20050222042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814109 | Method for modification of NMDA receptors through inhibition of Src | Mar 29, 2004 | Issued |
Array
(
[id] => 7185007
[patent_doc_number] => 20050191710
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Method for labeling a membrane-localized protein'
[patent_app_type] => utility
[patent_app_number] => 10/790273
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9386
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790273
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790273 | Method for labeling a membrane-localized protein | Feb 29, 2004 | Abandoned |
Array
(
[id] => 7276620
[patent_doc_number] => 20040236071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Methods and compositions for the treatment of diseases associated with signal transduction aberrations'
[patent_app_type] => new
[patent_app_number] => 10/786774
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 27726
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20040236071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786774
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786774 | Methods and compositions for the treatment of diseases associated with signal transduction aberrations | Feb 24, 2004 | Issued |
Array
(
[id] => 7088527
[patent_doc_number] => 20050008639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Methods of modulating homing of T cell by interruption of chemokine/chemokine receptor signaling'
[patent_app_type] => utility
[patent_app_number] => 10/777883
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16992
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777883
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777883 | Methods of modulating homing of T cell by interruption of chemokine/chemokine receptor signaling | Feb 11, 2004 | Abandoned |
Array
(
[id] => 7311055
[patent_doc_number] => 20040143096
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Mammalian cytokine-like factor 7'
[patent_app_type] => new
[patent_app_number] => 10/772985
[patent_app_country] => US
[patent_app_date] => 2004-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14240
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143096.pdf
[firstpage_image] =>[orig_patent_app_number] => 10772985
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/772985 | Mammalian cytokine-like factor 7 | Feb 4, 2004 | Abandoned |
Array
(
[id] => 7426873
[patent_doc_number] => 20040265819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Kidney-specific urate transporter and gene thereof'
[patent_app_type] => new
[patent_app_number] => 10/485236
[patent_app_country] => US
[patent_app_date] => 2004-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4778
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265819.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485236
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485236 | Kidney-specific urate transporter and gene thereof | Jan 28, 2004 | Abandoned |
Array
(
[id] => 7347625
[patent_doc_number] => 20040248099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Use of intermediate -conductance potassium channels and modulators for diagnosing and treating diseases having disturbed keratinocyte activity'
[patent_app_type] => new
[patent_app_number] => 10/451805
[patent_app_country] => US
[patent_app_date] => 2004-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 26814
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248099.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451805 | Use of intermediate -conductance potassium channels and modulators for diagnosing and treating diseases having disturbed keratinocyte activity | Jan 7, 2004 | Abandoned |
Array
(
[id] => 7374863
[patent_doc_number] => 20040219600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Method for determining sensitivity to environmental toxins and susceptibility to parkinson\'s disease'
[patent_app_type] => new
[patent_app_number] => 10/734372
[patent_app_country] => US
[patent_app_date] => 2003-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16094
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219600.pdf
[firstpage_image] =>[orig_patent_app_number] => 10734372
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/734372 | Method for determining sensitivity to environmental toxins and susceptibility to parkinson's disease | Dec 11, 2003 | Abandoned |